Bryce Point Capital, LLC Portfolio Holdings

Bryce Point Capital, LLC

  • $81.9 Billion
  • Q3 2025

Bryce Point Capital, LLC has filed its 13F form on November 06, 2025 for Q3 2025 where it was disclosed a total value porftolio of $81.9 Billion distributed in 168 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Freshpet, Inc. with a value of $753M, Wayfair Inc. with a value of $739M, Trans Medics Group, Inc. with a value of $688M, Option Care Health, Inc. with a value of $687M, and Teleflex Inc with a value of $688M.

Examining the 13F form we can see an decrease of $36.2B in the current position value, from $118B to 81.9B.

Bryce Point Capital, LLC is based out at Scarsdale, NY

Below you can find more details about Bryce Point Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $81.9 Billion
Technology: $14.2 Billion
Healthcare: $11.7 Billion
Financial Services: $10.7 Billion
Industrials: $9.97 Billion
Consumer Cyclical: $9.5 Billion
Basic Materials: $5.51 Billion
Consumer Defensive: $5.35 Billion
Utilities: $3.42 Billion
Other: $5.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.02B
$497 Million 0.61% of portfolio
4,320
Q3 2025 New
$19.5B
$495 Million 0.6% of portfolio
15,524
Q3 2025 Reduced 21.32%
$1.3B
$495 Million 0.6% of portfolio
64,084
Q3 2025 New
$1.86B
$491 Million 0.6% of portfolio
7,749
Q3 2025 Reduced 56.83%
Loar Holdings Inc
-
$494 Million 0.6% of portfolio
-
Q3 2025 Reduced 30.08%
$25.4B
$488 Million 0.6% of portfolio
6,860
Q3 2025 New
$4.91B
$481 Million 0.59% of portfolio
10,941
Q3 2025 Reduced 31.5%
$5.17B
$474 Million 0.58% of portfolio
4,060
Q3 2025 New
$3.7B
$478 Million 0.58% of portfolio
8,312
Q3 2025 New
$2.05B
$474 Million 0.58% of portfolio
43,864
Q3 2025 Reduced 50.54%
$5.87B
$479 Million 0.58% of portfolio
10,126
Q3 2025 New
$4.72B
$479 Million 0.58% of portfolio
9,020
Q3 2025 Reduced 41.66%
$1.57B
$476 Million 0.58% of portfolio
6,816
Q3 2025 New
$8.27B
$475 Million 0.58% of portfolio
77,673
Q3 2025 Added 101.02%
$4.71B
$470 Million 0.57% of portfolio
11,884
Q3 2025 Added 20.08%
$1.88B
$469 Million 0.57% of portfolio
39,197
Q3 2025 New
$2.63B
$463 Million 0.57% of portfolio
6,319
Q3 2025 New
$2.39B
$467 Million 0.57% of portfolio
3,545
Q3 2025 New
$16.9B
$461 Million 0.56% of portfolio
5,135
Q3 2025 New
$10B
$460 Million 0.56% of portfolio
14,983
Q3 2025 New
$1.11B
$455 Million 0.55% of portfolio
22,199
Q3 2025 Reduced 59.06%
$2.44B
$451 Million 0.55% of portfolio
8,756
Q3 2025 Reduced 23.85%
$633M
$450 Million 0.55% of portfolio
2,539
Q3 2025 Reduced 42.85%
$9.99B
$445 Million 0.54% of portfolio
4,968
Q3 2025 New
$5.07B
$441 Million 0.54% of portfolio
5,262
Q3 2025 New
$53.1B
$435 Million 0.53% of portfolio
1,369
Q3 2025 New
$25.4B
$429 Million 0.52% of portfolio
1,673
Q3 2025 Reduced 50.79%
$12.7B
$421 Million 0.51% of portfolio
4,511
Q3 2025 New
$64.9B
$412 Million 0.5% of portfolio
4,900
Q3 2025 Reduced 10.12%
$2.01B
$412 Million 0.5% of portfolio
7,701
Q3 2025 Reduced 41.2%
$14.3B
$401 Million 0.49% of portfolio
26,506
Q3 2025 Reduced 40.47%
$40.4B
$405 Million 0.49% of portfolio
3,197
Q3 2025 New
Primo Brands Corporation
-
$402 Million 0.49% of portfolio
-
Q3 2025 New
$187B
$385 Million 0.47% of portfolio
564
Q3 2025 Reduced 42.33%
$165B
$376 Million 0.46% of portfolio
4,980
Q3 2025 Reduced 41.38%
Cidara Therapeutics Inc
-
$381 Million 0.46% of portfolio
-
Q3 2025 New
$1.86B
$377 Million 0.46% of portfolio
16,914
Q3 2025 New
$3.46B
$358 Million 0.44% of portfolio
4,774
Q3 2025 New
$46.4B
$363 Million 0.44% of portfolio
1,508
Q3 2025 Reduced 47.58%
$3.55B
$335 Million 0.41% of portfolio
5,921
Q3 2025 New
Linde PLC
-
$328 Million 0.4% of portfolio
-
Q3 2025 New
$3.05B
$305 Million 0.37% of portfolio
11,612
Q3 2025 Reduced 38.37%
$2.16B
$295 Million 0.36% of portfolio
23,497
Q3 2025 New
$1.92B
$275 Million 0.34% of portfolio
25,758
Q3 2025 Reduced 46.41%
$2.41B
$269 Million 0.33% of portfolio
5,619
Q3 2025 New
Kiniksa Pharmaceuticals Intl
-
$265 Million 0.32% of portfolio
-
Q3 2025 New
Disc Medicine Inc
-
$259 Million 0.32% of portfolio
-
Q3 2025 New
$1.38B
$255 Million 0.31% of portfolio
5,171
Q3 2025 New
$11.3B
$233 Million 0.28% of portfolio
676
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 168
  • Current Value $81.9 Billion
  • Prior Value $118 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 06, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 103 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 54 stocks
Track This Portfolio

Track Bryce Point Capital, LLC Portfolio

Follow Bryce Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryce Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bryce Point Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email